Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients

In prostate cancer (PCa), cancer‐associated fibroblasts (CAFs) promote tumor progression, drug resistance, and metastasis. Although circulating tumor cells are studied as prognostic and diagnostic markers, little is known about other circulating cells and their association with PCa metastasis. Here,...

Full description

Saved in:
Bibliographic Details
Main Authors: Richell Booijink, Leon W. M. M. Terstappen, Eshwari Dathathri, Khrystany Isebia, Jaco Kraan, John Martens, Ruchi Bansal
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:Molecular Oncology
Subjects:
Online Access:https://doi.org/10.1002/1878-0261.13653
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839636247307354112
author Richell Booijink
Leon W. M. M. Terstappen
Eshwari Dathathri
Khrystany Isebia
Jaco Kraan
John Martens
Ruchi Bansal
author_facet Richell Booijink
Leon W. M. M. Terstappen
Eshwari Dathathri
Khrystany Isebia
Jaco Kraan
John Martens
Ruchi Bansal
author_sort Richell Booijink
collection DOAJ
description In prostate cancer (PCa), cancer‐associated fibroblasts (CAFs) promote tumor progression, drug resistance, and metastasis. Although circulating tumor cells are studied as prognostic and diagnostic markers, little is known about other circulating cells and their association with PCa metastasis. Here, we explored the presence of circulating CAFs (cCAFs) in metastatic castration‐naïve prostate cancer (mCNPC) patients. cCAFs were stained with fibroblast activation protein (FAP), epithelial cell adhesion molecule (EpCAM), and receptor‐type tyrosine‐protein phosphatase C (CD45), then FAP+EpCAM− cCAFs were enumerated and sorted using fluorescence‐activated cell sorting. FAP+EpCAM− cCAFs ranged from 60 to 776 (389 mean ± 229 SD) per 2 × 108 mononuclear cells, whereas, in healthy donors, FAP+ EpCAM− cCAFs ranged from 0 to 71 (28 mean ± 22 SD). The mCNPC‐derived cCAFs showed positivity for vimentin and intracellular collagen‐I. They were viable and functional after sorting, as confirmed by single‐cell collagen‐I secretion after 48 h of culturing. Two cCAF subpopulations, FAP+CD45− and FAP+CD45+, were identified, both expressing collagen‐I and vimentin, but with distinctly different morphologies. Collectively, this study demonstrates the presence of functional and viable circulating CAFs in mCNPC patients, suggesting the role of these cells in prostate cancer.
format Article
id doaj-art-00b22fbdea0f46edb758521fb0c6c88b
institution Matheson Library
issn 1574-7891
1878-0261
language English
publishDate 2025-07-01
publisher Wiley
record_format Article
series Molecular Oncology
spelling doaj-art-00b22fbdea0f46edb758521fb0c6c88b2025-07-08T04:38:21ZengWileyMolecular Oncology1574-78911878-02612025-07-011972074209110.1002/1878-0261.13653Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patientsRichell Booijink0Leon W. M. M. Terstappen1Eshwari Dathathri2Khrystany Isebia3Jaco Kraan4John Martens5Ruchi Bansal6Personalized Diagnostics and Therapeutics, Department of Bioengineering Technologies, Technical Medical Centre, Faculty of Science and Technology University of Twente Enschede The NetherlandsDepartment of Medical Cell BioPhysics, Technical Medical Centre, Faculty of Science and Technology University of Twente Enschede The NetherlandsDepartment of Medical Cell BioPhysics, Technical Medical Centre, Faculty of Science and Technology University of Twente Enschede The NetherlandsDepartment of Medical Oncology Erasmus MC Cancer Institute, University Medical Center Rotterdam The NetherlandsDepartment of Medical Oncology Erasmus MC Cancer Institute, University Medical Center Rotterdam The NetherlandsDepartment of Medical Oncology Erasmus MC Cancer Institute, University Medical Center Rotterdam The NetherlandsPersonalized Diagnostics and Therapeutics, Department of Bioengineering Technologies, Technical Medical Centre, Faculty of Science and Technology University of Twente Enschede The NetherlandsIn prostate cancer (PCa), cancer‐associated fibroblasts (CAFs) promote tumor progression, drug resistance, and metastasis. Although circulating tumor cells are studied as prognostic and diagnostic markers, little is known about other circulating cells and their association with PCa metastasis. Here, we explored the presence of circulating CAFs (cCAFs) in metastatic castration‐naïve prostate cancer (mCNPC) patients. cCAFs were stained with fibroblast activation protein (FAP), epithelial cell adhesion molecule (EpCAM), and receptor‐type tyrosine‐protein phosphatase C (CD45), then FAP+EpCAM− cCAFs were enumerated and sorted using fluorescence‐activated cell sorting. FAP+EpCAM− cCAFs ranged from 60 to 776 (389 mean ± 229 SD) per 2 × 108 mononuclear cells, whereas, in healthy donors, FAP+ EpCAM− cCAFs ranged from 0 to 71 (28 mean ± 22 SD). The mCNPC‐derived cCAFs showed positivity for vimentin and intracellular collagen‐I. They were viable and functional after sorting, as confirmed by single‐cell collagen‐I secretion after 48 h of culturing. Two cCAF subpopulations, FAP+CD45− and FAP+CD45+, were identified, both expressing collagen‐I and vimentin, but with distinctly different morphologies. Collectively, this study demonstrates the presence of functional and viable circulating CAFs in mCNPC patients, suggesting the role of these cells in prostate cancer.https://doi.org/10.1002/1878-0261.13653circulating cancer‐associated fibroblastcirculating tumor cellsfibroblast‐activated proteinliquid biopsymetastatic prostate cancer
spellingShingle Richell Booijink
Leon W. M. M. Terstappen
Eshwari Dathathri
Khrystany Isebia
Jaco Kraan
John Martens
Ruchi Bansal
Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients
Molecular Oncology
circulating cancer‐associated fibroblast
circulating tumor cells
fibroblast‐activated protein
liquid biopsy
metastatic prostate cancer
title Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients
title_full Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients
title_fullStr Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients
title_full_unstemmed Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients
title_short Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients
title_sort identification of functional and diverse circulating cancer associated fibroblasts in metastatic castration naive prostate cancer patients
topic circulating cancer‐associated fibroblast
circulating tumor cells
fibroblast‐activated protein
liquid biopsy
metastatic prostate cancer
url https://doi.org/10.1002/1878-0261.13653
work_keys_str_mv AT richellbooijink identificationoffunctionalanddiversecirculatingcancerassociatedfibroblastsinmetastaticcastrationnaiveprostatecancerpatients
AT leonwmmterstappen identificationoffunctionalanddiversecirculatingcancerassociatedfibroblastsinmetastaticcastrationnaiveprostatecancerpatients
AT eshwaridathathri identificationoffunctionalanddiversecirculatingcancerassociatedfibroblastsinmetastaticcastrationnaiveprostatecancerpatients
AT khrystanyisebia identificationoffunctionalanddiversecirculatingcancerassociatedfibroblastsinmetastaticcastrationnaiveprostatecancerpatients
AT jacokraan identificationoffunctionalanddiversecirculatingcancerassociatedfibroblastsinmetastaticcastrationnaiveprostatecancerpatients
AT johnmartens identificationoffunctionalanddiversecirculatingcancerassociatedfibroblastsinmetastaticcastrationnaiveprostatecancerpatients
AT ruchibansal identificationoffunctionalanddiversecirculatingcancerassociatedfibroblastsinmetastaticcastrationnaiveprostatecancerpatients